Product Images Lagevrio
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Lagevrio NDC 50090-6841 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
LAGEVRIO structure - lagevrio 01
Figure 1 - lagevrio 02
This text provides information regarding various factors related to COVID-19 treatment and outcomes. It includes details such as the time from symptom onset to randomization, age groups (<60 years and >60 years), sex (male/female), presence of obesity (BMI > 30), presence of diabetes mellitus, baseline COVID severity (mild/moderate), most common baseline clades (20J, 21A, 211, 217, 21H, and others), baseline antibody status (positive/negative), and the risk difference in percentage for different treatment groups. The text also includes numbers of events/subjects for each category, represented in a tabular format. Based on this information, further analysis can be done to understand the impact of these factors on COVID-19 outcomes.*
Label Image - lbl500906841
Product No. 7261-0 is a medication called "LAGEVRIO" with a strength of 200 mg. It is recommended to store this medication at a temperature of 81 to 100 degrees Fahrenheit.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.